Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | KEGG DRUG | DrugBank | Drug (Description in trials) | KEGG GENES | KEGG PATHWAY | Disease ID |
|---|---|---|---|---|---|---|
| 1 |
Nadolol
💬 (Nadolol (JP18/USP/INN)) | [1] Nadolol Nadolol (Ratio-nadolol Tab 40mg) | [1] Nadolol Nadolol | [2] ADRB1 ADRB1,ADRB2 💬 | [11] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 6 6 💬
|
| 2 | Bendroflumethiazide 💬 | [1] Bendroflumethiazide Bendroflumethiazide (Nadolol and Bendroflumethiazide) | [1] BENDROFLUMETHIAZIDE BENDROFLUMETHIAZIDE | [1] SLC12A3 SLC12A3 💬
| [1] 💬 | [1] 67 67 💬
|